Global Renal Denervation Market in the forecast period 2022-2029. The expected CAGR of global renal denervation market is tend to be around 31.60% in the mentioned forecast period. The market was valued at USD 599.87 million in 2021, and will reach USD 5396.40 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Renal denervation is a minimally-invasive catheter based treatment that is used for hypertension. Radiofrequency ablation is used to burn nerves in the renal arteries. Nerve activity decreases and blood pressure decreases. If pharmacological treatment does not result in relief, this procedure is usually used to achieve better results. The nerves in the renal artery wall are removed using high frequency pulses or ultrasound. It lowers blood pressure by reducing the activity of the sympathetic kidneys.
Global Renal Denervation Market Scope
The global renal denervation market is segmented on the basis of product, technology, type, indication and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Simplicity Renal Denervation System
- Vessix Renal Denervation System
- Paradise Renal Denervation System
- Iberis Renal Sympathetic Denervation System
Competitive Landscape and Global Renal Denervation Market Share Analysis
The global renal denervation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to renal denervation market.
Key players operating in the global renal denervation market include:
- Medtronic (US)
- Boston Scientific Corporation (US)
- Abbott (US)
- ReCor Medical, Inc. (US)
- Johnson & Johnson Private Limited (US),
- Terumo Corporation (Japan)
- Mercator MedSystems,Inc. (US)
- Ablative Solutions, Inc. (US)
- SympleSurgical Inc. (US)
- Kona Medical Inc. (U.S.)
- Renal Dynamics Limited (U.K.)
- Otsuka Medical Devices Co., Ltd. (Tokyo)
Access Full Report:-
Renal Denervation Market Regional Analysis/Insights
The global renal denervation market is analysed and market size insights and trends are provided by product, technology, type, indication and end-user as referenced above.
The major countries covered in the global renal denervation market are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Request Access for Sample Report:-
Major TOC of the Report
2 MARKET SEGMENTATION
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
Get TOC of the Report:-
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Data Bridge Market Research
Browse Related Reports@